DexCom Executive Chairman and Director Terry Gregg Retires
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
DexCom (DXCM) PT Raised to $125 at Oppenheimer
August 2, 2018 9:29 AM EDTOppenheimer raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $85.00) while maintaining an Outperform rating.
Analyst Steven Lichtman commented, "DexCom's 2Q18 sales of $243M (+41% cc) delivered a strong beat versus our/consensus $202/$206M forecasts, led by robust outperformance in both US and... More
DexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr
August 2, 2018 7:59 AM EDTCowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.
Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More
